We found that ALK knockdown also significantly reduced phospho-CRKL level (Figure 2E), indicating that CRKL indeed is a downstream molecule of ALK in the EML4-ALK positive NSCLC cells. The gene discussed is EML4; the disease is non-small cell lung carcinoma.